Early-stage initiative · Service in development · Synthetic demonstration · Not available for purchase
In development and validation

Make accessibility regressions easier to act on.

Macelyr Ventures is an early-stage B2B technology and services initiative developing a white-label triage workflow for digital agencies: compare controlled releases, prioritize potential accessibility regressions, and turn evidence into developer-ready tickets.

Proposed service

Regression evidence for agency delivery teams.

The concept is intended for web and digital agencies that already ship client sites and need a repeatable way to spot selected accessibility risks introduced between releases—without presenting automation as a complete accessibility review.

  • 01
    Target customer
    Small and mid-sized agencies managing recurring website releases.
  • 02
    Operating role
    A white-label evidence and triage layer supporting an agency’s own QA and client communication.
  • 03
    Practical outcome
    Prioritized observations, reproduction steps, suggested tickets, and a documented retest.
Capability boundary

Demonstrated now is not the same as proposed later.

The V2 presentation separates the evidence produced by this controlled prototype from capabilities that would require additional tooling, delivery processes, and qualified human review.

Current demonstration capabilities

Working and repeatable inside the controlled synthetic project.

  • Controlled synthetic HTML testing
  • Four selected automated heuristic checks
  • Baseline-to-regression finding comparison
  • Demonstration severity classification
  • Developer-oriented findings and ticket drafts
  • Simulated remediation and documented retesting
  • Sample HTML and PDF report generation

Proposed future service capabilities

Concepts only; not represented as commercially operational.

  • Broader accessibility regression testing
  • Manual keyboard testing
  • NVDA/Chrome review
  • Qualified specialist triage
  • Recurring release-batch evaluation
  • White-label agency reporting
  • Managed retesting

What this demonstration proves

A controlled release comparison can preserve evidence, identify four intentionally introduced HTML-pattern regressions, prioritize them, produce developer-oriented remediation information, and record a zero-finding retest after simulated fixes.

What remains unverified

Real customer delivery, production-scale tooling, manual assistive-technology review, specialist capacity, service cadence, privacy operations, and market acceptance remain untested.

Controlled workflow

From known baseline to documented retest.

The local demonstration uses three versions of the same fictional page and a bounded checker for selected HTML patterns.

01 / BASELINE

Observe

Record the controlled starting page and tool scope.

02 / CHANGE

Compare

Introduce a known change set and identify new findings.

03 / TRIAGE

Prioritize

Rank impact, preserve evidence, and draft remediation tickets.

04 / RETEST

Confirm

Apply a simulated fix and rerun the same bounded checks.

Proposed deliverables

Designed to be useful inside an agency workflow.

Regression triage report

Release comparison, prioritized findings, evidence, reproduction steps, suggested remediation, and retest state.

Developer ticket drafts

Concise implementation-oriented issue descriptions that an agency can adapt to its own tracker.

Evidence package

Machine-readable check output and a human-readable transcript tied to a controlled test target.

White-label presentation layer

A report structure intended to support agency review without implying Macelyr Ventures performed services for an end client.

Representative sample

A finding should tell a developer what changed and what to do next.

The example below comes from the included synthetic regression page. It is genuine output from the project’s limited checker, not evidence from a customer website.

DEMONSTRATION — SYNTHETIC TEST SITE — NOT CLIENT WORKRUN: REGRESSION
CRITICAL

Icon-only button has no accessible name

Evidence: the controlled change replaced visible button text with an aria-hidden arrow. Suggested ticket: restore descriptive visible text or provide an accurate accessible name.

RETEST: PASS
HIGH

Email field lost its associated label

Evidence: the input retains a placeholder but no label or accessible-name relationship. Suggested ticket: restore the visible label and for/id association.

RETEST: PASS
HIGH

Informative image is missing alternative text

Evidence: the regression image element has no alt attribute. Suggested ticket: supply concise equivalent text or mark it decorative with empty alt text.

RETEST: PASS
Project background

An independently developed, early-stage B2B technology initiative.

Macelyr Ventures is being developed independently to explore practical, evidence-led services for digital delivery teams. This controlled demonstration shows the accessibility regression triage concept and the quality of a representative deliverable; it does not represent an incorporated company, established commercial operation, existing customer work, professional credentials, partnerships, or completed engagements.

No personal contact details are published. Any future launch, customer communication, delivery commitments, or specialist-review arrangements would require separate owner approval and operational validation.

Commercial model under validation

A fixed monthly concept with deliberately bounded scope.

The proposed model is one recurring regression-triage cycle for one website, structured for agencies that need predictable output after controlled releases.

Not a legal opinion
No legal assurance or regulatory determination.
Not a compliance guarantee
Automated testing does not establish WCAG compliance.
No represented manual review
No manual NVDA or specialist review is represented in this demonstration.
No production monitoring claim
Availability, cadence, and delivery capacity remain to be validated.
Development status: This prototype demonstrates a service concept and controlled technical workflow. Delivery capacity, specialist review arrangements, customer terms, insurance, privacy procedures, production tooling, and commercial readiness have not been established.